Research demonstrates that age-related inflammatory changes contribute to accelerated COPD development, especially when combined with cigarette smoke exposure. This knowledge provides new directions for innovative treatment approaches.
Researchers at Helmholtz Zentrum München have found that the viral protein LMP2A helps EBV-infected cells evade immune detection. This may contribute to the development of cancer, particularly in nasopharyngeal carcinoma and Hodgkin's lymphoma.
Researchers have created a detailed atlas of surface proteins on naive CD4+ T cells, which play a crucial role in the development of immunological memory. The findings provide insights into the cell's maturation process and could lead to new therapeutic approaches for allergies and asthma.
Researchers at Helmholtz Munich developed an assay to rebuild mammary gland tissue architecture using human breast epithelial cells. The mini-mammary glands exhibit properties similar to those of aggressive breast cancer cells, suggesting a link between normal breast stem cell function and tumor progression.
Researchers at Helmholtz Munich have identified FKBP10 as a potential new target molecule for treating idiopathic pulmonary fibrosis (IPF), a chronic lung disease. Analysis of patient data revealed elevated levels of the protein in IPF patients, which may lead to a new therapeutic approach.
Researchers at Helmholtz Munich have developed a new method to validate drug targets for chronic obstructive pulmonary disease (COPD) treatment. The technique enables the study of lung tissue repair mechanisms in patient-derived tissues, providing valuable insights into COPD pathologies and potential therapeutic avenues.
Scientists at Helmholtz Munich discovered a novel lncRNA called PARTICLE that regulates cells' response to ionizing radiation by limiting DNA methylation. This finding contradicts the established LNT model and raises questions about the risk of low-dose radiation exposure.
Scientists at Helmholtz Zentrum München have identified a new isoform of neutrophil elastase involved in the pathogenesis of pulmonary emphysema. The cleaved form of the enzyme is particularly aggressive and resistant to inhibitors, leading to increased tissue damage.
A study by Helmholtz Munich researchers found that exposure to ultrafine particles can induce immediate changes in heart rate variability in individuals with impaired glucose metabolism or diabetes. The research suggests potential health risks and demands for threshold limit values for environmental standards.
Researchers at Helmholtz Munich found associations between weight change and lipid, amino acid metabolism, insulin sensitivity, mitochondrial functioning, and red blood cell development. The study provides new insights into the molecular mechanisms affected by weight gain.
The generation of neurons in humans is limited to development, and this process declines with age due to the limited self-renewal of neural stem cells. Therapeutic approaches must focus on maintaining stem cell supply by promoting their self-renewal rate.
Researchers have developed nanocarriers that selectively release drugs in lung tumor areas, improving treatment efficacy by 10-25 times compared to traditional methods. This approach also reduces the total dose of medicines, minimizing undesirable effects.
Researchers at Helmholtz Zentrum München developed an approach to quantify gadolinium-based contrast agents in tissue using MALDI-MS imaging, correlating it with MRI images. This combination improves diagnostic value by detecting tissue-related kinetics of contrast agents used in myocardial infarction models.
Researchers discovered that Twist1, a developmental regulator, primes cells for stem-cell-like properties when activated transiently. This leads to cellular plasticity and regenerative potential. Conversely, chronic Twist1 activity promotes invasive, non-proliferative phenotypes in tumor cells.
Researchers have successfully designed a substance combining three metabolically active hormone components (GLP-1, GIP, and glucagon) to fight metabolic diseases. The triple hormone reduces body weight by around 30 percent while improving insulin sensitivity, essentially curing obesity and diabetes in animal models.
Climate change alters soil microorganisms' metabolic activity and composition, positively stimulating denitrification and increasing N2O emission rates. This shift impacts plant-microbe competition for nitrogen, with implications for ecosystem function and global climate.
Researchers have discovered ferroptosis, a regulated form of necrosis that occurs in various pathological conditions. Ferroptosis inhibitors, such as Liproxstatin-1, offer novel therapeutic opportunities to mitigate diseases previously thought to be untreatable.
Scientists found that cilia play a crucial role in the release and signal transduction of insulin, a hormone that reduces sugar levels. Ciliary dysfunction leads to impaired insulin secretion and increased blood sugar levels, linking it to type 2 diabetes.
A new biomarker, CLIP2, has been discovered that distinguishes between radiation-induced and sporadic thyroid carcinomas. The marker increases in both genetic activity and protein expression after radiation exposure.
A team of scientists led by Prof. Mathias Heikenwälder found that immune cells, particularly CD8+ T cells and NK T cells, play a crucial role in the development of fatty liver disease, non-alcoholic steatohepatitis (NASH), and liver cancer. The study suggests that an existing metabolic imbalance triggers the activation and migration of...
Researchers at Helmholtz Munich have created a novel fluorescent marker that excites in the far-red spectrum and emits in the infrared range, enabling better-quality images with advanced bio-imaging. This technology allows for the delineation of tumor and metastasis, tracking drug responses within whole-body imaging.
Scientists have unraveled a molecular mechanism of mRNA recognition, essential for understanding differential gene regulation in male and female organisms. This principle represents an essential and widespread mechanism of gene regulation in higher organisms.
Research found that cystic fibrosis patients have a deficiency in the immune system, specifically with HLA-DQ molecules on their cells. This deficiency affects the body's ability to fight off infections and is linked to the disease's progression.
Researchers discovered microbial communities within oil droplets, degrading oil and reducing its quality. This finding could pave the way for new approaches to clean up contaminated groundwater.
A study by Helmholtz Munich found that individuals with high workplace stress and low control have a 45% higher risk of developing type 2 diabetes. The researchers analyzed data from over 5,300 employed individuals and identified the link independently of classic risk factors.
Scientists have discovered how combining metformin with SGLT2 inhibitors reinforces each other, reducing blood sugar levels effectively and prolongingly. This new approach has the potential to be an effective treatment strategy for type 2 diabetes with minimal side effects.
Researchers at Helmholtz Munich have developed a new approach to treat obesity and type 2 diabetes, targeting the brown adipose tissue. By identifying specific surface proteins, they aim to selectively deliver substances to this tissue to reduce excess weight without side effects.
A study by Helmholtz Munich found that extreme heat and cold increase mortality rates, particularly among the elderly with pre-existing medical conditions. The researchers observed a significant rise in cardiovascular events and stroke during hot temperatures and up to two weeks after cold weather.
Scientists at Helmholtz Munich have gained new insights into the complex gene-regulatory interactions in bread wheat, enabling them to better understand how a polyploid genome is regulated. The study's findings hold promise for improving breeding, agricultural cultivation and industrial properties of bread wheat.
A team of scientists has revealed the molecular mechanisms underlying Roquin's role in preventing autoimmune diseases. The study found that Roquin recognizes a range of RNA binding partners to control T-cell functions, regulating a larger number of genes than previously thought.
Researchers at Helmholtz Munich have created a diagnostic procedure that uses only two genes to reliably differentiate between psoriasis and eczema. The new test is expected to pave the way for personalized medicine in chronic inflammatory skin diseases, reducing the need for expensive treatments.
A team of researchers has identified six new gene loci associated with forced vital capacity, a volume parameter of lung function. The study suggests involvement of these genes in lung development and certain pulmonary diseases.
Researchers have developed a new imaging technique using X-ray dark-field radiography to detect lung diseases at an earlier stage. This method provides detailed images of soft tissue, enabling the visualization of structural changes in lung tissue.
Scientists have discovered how hepatitis C virus proteins interact within human cells, revealing a better understanding of viral replication and pathogenesis. This knowledge paves the way for developing new antiviral substances with low cellular toxicity.
A study published by Helmholtz Munich researchers found that patients with good diabetes self-management have a significantly lower mortality risk than those with poor self-management. The study, which analyzed data from 340 participants, showed that active participation in treatment and lifestyle modifications can lead to better healt...
Researchers found that gut microbiota diversity and interaction networks vary significantly between children with and without autoantibodies, influencing the body's immune system. The study suggests that identifying parameters affecting negative microbiome characteristics can lead to new approaches in preventing autoimmune processes.
Researchers at Helmholtz Munich have found that GAD antibody affinity is a key indicator of LADA disease progression. The study used GAD vaccination to examine the impact on antibody affinity in 46 LADA patients, finding no influence from vaccination. Patients with high affinity had low insulin production and required insulin therapy s...
A research team developed an adjuvant that optimizes lentivirus gene transfer by enhancing virus attachment to target cells, resulting in a three-fold increase in transduction rate. This improvement reduces the need for additional viruses, potentially leading to more effective treatments for genetic disorders.
Research finds that living in a socioeconomically deprived region increases the risk of diabetes and obesity, regardless of individual social status. The study analyzed data from over 33,000 people and found significant correlations between regional deprivation and type 2 diabetes and obesity rates.
Researchers found that children with prediabetes and multiple islet autoantibodies had lower vitamin D levels, which increased during summer months. Vitamin D supplementation may be recommended at an early stage to prevent deficiency.
Scientists have discovered a way to selectively degrade viral DNA in the cell nucleus of infected liver cells, opening up new treatment options for hepatitis B. This breakthrough may allow for the development of a treatment that can heal hepatitis B without damaging the host cell.
Researchers from Helmholtz Munich demonstrate that geranium extracts inhibit HIV-1 virus replication by blocking attachment to host cells. The extracts contain polyphenols with high anti-HIV-1 activity, making them a promising lead for phytomedicine against HIV-1.
Researchers at Helmholtz Munich have made a breakthrough in creating insulin-producing beta cells from stem cells. By understanding the molecular regulation of stem cell differentiation, they can generate functional specialized cells for regenerative therapy approaches to chronic diseases like diabetes. This discovery has significant i...
A new peptide treatment has been shown to restore leptin responsiveness, improve body weight and glucose metabolism in obese mice fed a high-fat, high-sugar diet. The treatment overcomes leptin resistance, a major obstacle in treating obesity and type 2 diabetes.
The study reveals how lymphotoxins control the production of immunoglobulin A (IgA) in the gut, maintaining immunological balance. Lacking lymphotoxins can lead to reduced or halted IgA production and changes in intestinal flora.
A gut hormone test may predict the extent of metabolic improvement caused by gastric bypass surgery. The test measures GLP-1 responsiveness, which varies from patient to patient and correlates with glucose metabolism improvements.
Scientists from Helmholtz Zentrum Muenchen discovered new associations between two major Type 2 diabetes risk genotypes and altered plasma concentrations of metabolic products. The study, published in PLOS ONE and Metabolomics, reveals specific metabolic effects, particularly for the TCF7L2 genotype.
Scientists have developed a new therapeutic approach for Type 2 diabetes using a novel single molecule hormone that acts on GLP-1 and GIP receptors. The hormone reduces weight and improves blood sugar levels, and may offer unprecedented potential for personalized therapies.
A novel surgical intervention involves placing an intestinal barrier sleeve in the small intestine to correct obesity and improve glucose metabolism. The method is less invasive and can be removed at any time.
Researchers investigated how drug treatment affects signal carriers in diabetic retinas, finding half of proteins normalized by metformin treatment. However, other essential proteins remained unchanged despite improved blood glucose levels, suggesting a need for further combination therapies to effectively treat diabetic retinopathy.